Clin2
NCT07591012Likely a fitRecruiting

Probiotic Supplements for Ulcerative Colitis Remission

Ulcerative Colitis (Disorder)

Part of Digestive system clinical trials.

This trial tests whether taking sodium butyrate (a short-chain fatty acid) and a specific probiotic yeast called Kluyveromyces marxianus can help keep ulcerative colitis in remission and prevent flare-ups. You'd need to be in remission (symptom-free with no active inflammation) when you start.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
40 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • You have been diagnosed with ulcerative colitis (UC) confirmed by blood tests, a colonoscopy, and tissue samples
  • Your UC is currently in remission—meaning no active symptoms or inflammation right now
  • You are between 18 and 75 years old
  • You have not taken antibiotics or probiotics in the 10 days before the trial starts
  • You are not pregnant
  • You do not have Crohn's disease, indeterminate colitis, or other types of inflammatory bowel disease

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06642883Recruiting
A supplement for gut health in ulcerative colitis remission

This study tests a supplement called ProLife 10 FORTE to see if it affects the natural balance of gut bacteria in people with ulcerative colitis (UC) that is in remission. If you have UC that is not active and you meet other health criteria, you may be able to join.

Padua, Padua
NCT07724990Recruiting
Probiotic for gut health in mild-to-moderate colitis

This trial tests a specific probiotic (a type of beneficial bacteria) to see if it can help people with mild to moderate ulcerative colitis by improving the balance of gut microbes. It may be an option if you have not used many advanced treatments before.

Roma, RM
NCT07263880Not yet recruiting· Phase 1/Phase 2
Clostridium Butyricum for stricturing Crohn's disease

This trial tests a bacteria called Clostridium butyricum to see if it can help people with a type of Crohn's disease that causes narrowing in the right colon or ileocecal area. It may offer a new option for those not on strong immune-suppressing medications.

Roma
NCT07519616Not yet recruiting
Probiotic bacteria for colonoscopy-related stomach symptoms

This study tests whether a specific probiotic (beneficial bacteria called Colipral®) can reduce stomach discomfort after a colonoscopy. You would take this probiotic after your colonoscopy procedure to see if it helps with symptoms like bloating or cramping.

Urbino
NCT06495658Recruiting
Prebiotics for ulcerative colitis symptoms

This trial tests whether a prebiotic supplement can improve symptoms of ulcerative colitis. It may be a good option for people with active symptoms who are already on stable medications.

Los Angeles, California
NCT04373473Recruiting· Phase 2
Oral stool treatment to prevent ulcerative colitis flare-ups

This study tests whether taking freeze-dried (lyophilized) donor stool material by mouth can help prevent ulcerative colitis from coming back or causing intestinal inflammation. Participants are in remission and stay on their usual treatment while receiving the study product.

Houston, Texas

Hear when a new Ulcerative Colitis (Disorder) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.